BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31558266)

  • 1. Expression and regulation of telomerase in human T cell differentiation, activation, aging and diseases.
    Patrick M; Weng NP
    Cell Immunol; 2019 Nov; 345():103989. PubMed ID: 31558266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and Effect of Telomerase and Telomeric Length in Stem Cells.
    Celtikci B; Erkmen GK; Dikmen ZG
    Curr Stem Cell Res Ther; 2021; 16(7):809-823. PubMed ID: 32321410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging.
    Weng NP; Palmer LD; Levine BL; Lane HC; June CH; Hodes RJ
    Immunol Rev; 1997 Dec; 160():43-54. PubMed ID: 9476664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomeres and immunological diseases of aging.
    Andrews NP; Fujii H; Goronzy JJ; Weyand CM
    Gerontology; 2010; 56(4):390-403. PubMed ID: 20016137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase is required for zebrafish lifespan.
    Henriques CM; Carneiro MC; Tenente IM; Jacinto A; Ferreira MG
    PLoS Genet; 2013; 9(1):e1003214. PubMed ID: 23349637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length and telomerase activity in T cells are biomarkers of high-performing centenarians.
    Tedone E; Huang E; O'Hara R; Batten K; Ludlow AT; Lai TP; Arosio B; Mari D; Wright WE; Shay JW
    Aging Cell; 2019 Feb; 18(1):e12859. PubMed ID: 30488553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity and telomere length in Daphnia.
    Schumpert C; Nelson J; Kim E; Dudycha JL; Patel RC
    PLoS One; 2015; 10(5):e0127196. PubMed ID: 25962144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting the telomere machinery to put the brakes on inflamm-aging.
    Bonafè M; Sabbatinelli J; Olivieri F
    Ageing Res Rev; 2020 May; 59():101027. PubMed ID: 32068123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomeres and telomerase in human health and disease.
    Tzukerman M; Selig S; Skorecki K
    J Pediatr Endocrinol Metab; 2002 Mar; 15(3):229-40. PubMed ID: 11924925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere shortening and immune activity in war veterans with posttraumatic stress disorder.
    Jergović M; Tomičević M; Vidović A; Bendelja K; Savić A; Vojvoda V; Rac D; Lovrić-Čavar D; Rabatić S; Jovanovic T; Sabioncello A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():275-83. PubMed ID: 24977331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of U-STELA for Accurate Measurement of Extremely Short Telomeres.
    Serakinci N; Cagsin H; Mavis M
    Methods Mol Biol; 2019; 2045():217-224. PubMed ID: 29542055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of telomere shortening during lifespan.
    Henriques CM; Ferreira MG
    Curr Opin Cell Biol; 2012 Dec; 24(6):804-8. PubMed ID: 23127607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging.
    Piñeiro-Hermida S; Autilio C; Martínez P; Bosch F; Pérez-Gil J; Blasco MA
    J Cell Biol; 2020 Oct; 219(10):. PubMed ID: 32777016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing T Lymphocyte Aging Using Telomere Length and Telomerase Activity Measurements in Low Cell Numbers.
    Fali T; K'Ros C; Appay V; Sauce D
    Methods Mol Biol; 2019; 2048():231-243. PubMed ID: 31396941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo regulation of telomerase activity and telomere length.
    Hathcock KS; Jeffrey Chiang Y; Hodes RJ
    Immunol Rev; 2005 Jun; 205():104-13. PubMed ID: 15882348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
    Babizhayev MA; Yegorov YE
    J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
    Engelhardt M; Martens UM
    Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of telomerase modulation in human hematopoietic progenitor cells.
    Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
    Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosenescence phenotypes in the telomerase knockout mouse.
    Blasco MA
    Springer Semin Immunopathol; 2002; 24(1):75-85. PubMed ID: 11974584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening.
    Carrillo J; Calvete O; Pintado-Berninches L; Manguan-García C; Sevilla Navarro J; Arias-Salgado EG; Sastre L; Guenechea G; López Granados E; de Villartay JP; Revy P; Benitez J; Perona R
    Hum Mol Genet; 2017 May; 26(10):1900-1914. PubMed ID: 28369633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.